Related articles

• Randomized Controlled Trial

  Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial.

  J. Clin. Oncol. 2003 Mar 15; 21 (6): 968-75.

• Randomized Controlled Trial

  Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

  J. Clin. Oncol. 1999 May 1; 17 (5): 1413-24.

• Multicenter Study

  Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58.

  Clin. Breast Cancer. 2002 Dec 1; 3 (5): 333-40.

Show more related articles...